This CTD dossier owner and manufacturer is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

This pharmaceutical company specializes in the development and production of a wide range of generic and branded medications. Their manufacturing facility, located in an excise-free zone, is WHO-GMP certified and adheres to MHRA UK and TGA standards. They offer various dosage forms, including tablets, capsules, oral liquids, dry syrups, parenterals, MDIs, powders, and ointments. The company focuses on several key therapy areas such as antibiotics, anti-inflammatories, cardiovascular medications, anti-diabetic drugs, oncology products, and vitamins. They export their products to regions including Central Asia and the Caucasus.

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards